Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-21

Clinical Trial Update: A Study of Aspirin and Simvastatin in Pulmonary Arterial Hypertension [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating aspirin and simvastatin for pulmonary arterial hypertension was terminated, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)
  • SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: University of Pennsylvania | Conditions: Hypertension, Pulmonary | Phase 2 | Status: TERMINATED | Results posted: 2017-07-21